Crinetics Pharmaceuticals IncNASDAQ:CRNX
- LAST PRICE44.2000
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.0000 / 44.2000
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CRNX |
|---|---|---|
| 09:32 ET | 3631 | 43.875 |
| 09:34 ET | 455 | 43.9496 |
| 09:36 ET | 1917 | 44.015 |
| 09:38 ET | 600 | 44.04 |
| 09:39 ET | 750 | 44.05 |
| 09:41 ET | 2000 | 44.07 |
| 09:43 ET | 1413 | 44.25 |
| 09:45 ET | 300 | 44.43 |
| 09:48 ET | 400 | 44.31 |
| 09:50 ET | 700 | 44.2 |
| 09:52 ET | 100 | 44 |
| 09:54 ET | 500 | 43.95 |
| 09:56 ET | 1600 | 43.79 |
| 09:59 ET | 1500 | 43.93 |
| 10:01 ET | 500 | 43.79 |
| 10:03 ET | 308 | 43.8399 |
| 10:06 ET | 100 | 43.75 |
| 10:08 ET | 300 | 43.775 |
| 10:10 ET | 2804 | 43.84 |
| 10:14 ET | 400 | 43.97 |
| 10:15 ET | 100 | 43.955 |
| 10:17 ET | 2303 | 44.035 |
| 10:21 ET | 200 | 44.035 |
| 10:24 ET | 1600 | 43.97 |
| 10:26 ET | 1300 | 44.01 |
| 10:28 ET | 992 | 44.09 |
| 10:30 ET | 1100 | 44.135 |
| 10:32 ET | 1300 | 44.075 |
| 10:33 ET | 2259 | 44.19 |
| 10:35 ET | 100 | 44.23 |
| 10:37 ET | 300 | 44.115 |
| 10:39 ET | 300 | 44.155 |
| 10:42 ET | 100 | 44.15 |
| 10:44 ET | 2820 | 44.165 |
| 10:48 ET | 200 | 44.165 |
| 10:50 ET | 200 | 44.165 |
| 10:51 ET | 200 | 44.2 |
| 10:53 ET | 1400 | 44.255 |
| 10:55 ET | 400 | 44.29 |
| 10:57 ET | 300 | 44.3 |
| 11:00 ET | 700 | 44.315 |
| 11:02 ET | 1300 | 44.29 |
| 11:04 ET | 2750 | 44.21 |
| 11:06 ET | 200 | 44.32 |
| 11:08 ET | 6094 | 44.28 |
| 11:09 ET | 200 | 44.28 |
| 11:11 ET | 1001 | 44.28 |
| 11:13 ET | 5402 | 44.28 |
| 11:15 ET | 200 | 44.28 |
| 11:18 ET | 2716 | 44.23 |
| 11:20 ET | 200 | 44.275 |
| 11:22 ET | 900 | 44.12 |
| 11:24 ET | 900 | 44.09 |
| 11:26 ET | 100 | 44.042 |
| 11:27 ET | 500 | 43.981 |
| 11:29 ET | 600 | 44 |
| 11:31 ET | 100 | 43.913 |
| 11:33 ET | 400 | 43.919 |
| 11:36 ET | 500 | 43.919 |
| 11:38 ET | 7941 | 44.06 |
| 11:40 ET | 1000 | 44.06 |
| 11:42 ET | 800 | 44.06 |
| 11:44 ET | 100 | 44.11 |
| 11:45 ET | 2218 | 44.115 |
| 11:47 ET | 2843 | 44.125 |
| 11:49 ET | 1663 | 44.06 |
| 11:51 ET | 300 | 44.02 |
| 11:54 ET | 100 | 44.045 |
| 11:56 ET | 1000 | 43.995 |
| 11:58 ET | 200 | 44.035 |
| 12:00 ET | 100 | 44.035 |
| 12:02 ET | 1965 | 43.93 |
| 12:03 ET | 100 | 43.87 |
| 12:05 ET | 300 | 43.87 |
| 12:07 ET | 2287 | 43.86 |
| 12:12 ET | 100 | 43.895 |
| 12:14 ET | 500 | 43.9 |
| 12:18 ET | 200 | 43.9 |
| 12:20 ET | 100 | 43.89 |
| 12:21 ET | 600 | 43.98 |
| 12:23 ET | 300 | 43.95 |
| 12:27 ET | 300 | 44 |
| 12:30 ET | 400 | 44 |
| 12:32 ET | 1200 | 43.93 |
| 12:36 ET | 300 | 43.905 |
| 12:38 ET | 300 | 43.9 |
| 12:39 ET | 400 | 43.87 |
| 12:41 ET | 998 | 43.8328 |
| 12:45 ET | 300 | 43.88 |
| 12:48 ET | 200 | 43.84 |
| 12:50 ET | 954 | 43.885 |
| 12:52 ET | 100 | 43.85 |
| 12:54 ET | 100 | 43.885 |
| 12:56 ET | 200 | 43.86 |
| 12:57 ET | 1216 | 43.92 |
| 12:59 ET | 100 | 43.91 |
| 01:01 ET | 200 | 43.92 |
| 01:06 ET | 400 | 43.945 |
| 01:08 ET | 100 | 43.99 |
| 01:10 ET | 100 | 43.95 |
| 01:12 ET | 300 | 43.91 |
| 01:14 ET | 617 | 43.95 |
| 01:17 ET | 100 | 43.92 |
| 01:19 ET | 300 | 43.96 |
| 01:21 ET | 317 | 43.96 |
| 01:26 ET | 1600 | 43.98 |
| 01:28 ET | 700 | 43.95 |
| 01:32 ET | 300 | 43.95 |
| 01:35 ET | 2911 | 43.94 |
| 01:39 ET | 417 | 43.965 |
| 01:42 ET | 1200 | 44.005 |
| 01:44 ET | 600 | 43.98 |
| 01:46 ET | 200 | 44.02 |
| 01:48 ET | 100 | 44.015 |
| 01:50 ET | 100 | 43.98 |
| 01:51 ET | 323 | 44 |
| 01:53 ET | 200 | 43.95 |
| 01:55 ET | 200 | 43.91 |
| 01:57 ET | 500 | 43.98 |
| 02:00 ET | 1100 | 43.985 |
| 02:02 ET | 600 | 44 |
| 02:04 ET | 200 | 43.95 |
| 02:06 ET | 700 | 44 |
| 02:08 ET | 100 | 43.97 |
| 02:09 ET | 300 | 43.97 |
| 02:11 ET | 2164 | 44.02 |
| 02:13 ET | 200 | 44.02 |
| 02:15 ET | 756 | 43.95 |
| 02:18 ET | 436 | 43.97 |
| 02:20 ET | 933 | 43.955 |
| 02:22 ET | 100 | 43.955 |
| 02:26 ET | 400 | 43.92 |
| 02:27 ET | 765 | 44.015 |
| 02:29 ET | 3000 | 44.02 |
| 02:31 ET | 400 | 43.95 |
| 02:36 ET | 400 | 43.95 |
| 02:38 ET | 100 | 43.985 |
| 02:40 ET | 600 | 43.93 |
| 02:42 ET | 1343 | 43.945 |
| 02:45 ET | 200 | 43.955 |
| 02:47 ET | 100 | 43.93 |
| 02:49 ET | 413 | 43.97 |
| 02:51 ET | 322 | 43.92 |
| 02:54 ET | 1234 | 43.91 |
| 02:56 ET | 200 | 43.87 |
| 02:58 ET | 900 | 43.895 |
| 03:00 ET | 400 | 43.855 |
| 03:03 ET | 100 | 43.84 |
| 03:05 ET | 1371 | 43.905 |
| 03:07 ET | 900 | 43.915 |
| 03:09 ET | 2214 | 44.12 |
| 03:12 ET | 4267 | 44.035 |
| 03:14 ET | 100 | 44.01 |
| 03:18 ET | 200 | 44.02 |
| 03:20 ET | 100 | 44.07 |
| 03:21 ET | 1207 | 44.045 |
| 03:23 ET | 900 | 44.145 |
| 03:25 ET | 100 | 44.19 |
| 03:27 ET | 200 | 44.19 |
| 03:30 ET | 1268 | 44.12 |
| 03:32 ET | 253 | 44.125 |
| 03:34 ET | 300 | 44.1 |
| 03:36 ET | 400 | 44.14 |
| 03:38 ET | 703 | 44.25 |
| 03:39 ET | 1272 | 44.27 |
| 03:41 ET | 415 | 44.31 |
| 03:43 ET | 900 | 44.335 |
| 03:45 ET | 400 | 44.37 |
| 03:48 ET | 2000 | 44.26 |
| 03:50 ET | 1200 | 44.24 |
| 03:52 ET | 2017 | 44.2 |
| 03:54 ET | 3145 | 44.14 |
| 03:56 ET | 13506 | 44.185 |
| 03:57 ET | 20251 | 44.09 |
| 03:59 ET | 234280 | 44.2 |
Jul 2, 2024
DJ Crinetics Pharmaceuticals Is Maintained at Overweight by Piper Sandler, from 1:39PM ET on Tuesday Jul 02, 2024 by Dow Jones
1:39PM ET on Tuesday Jul 02, 2024 by Dow Jones
Jun 28, 2024
DJ Crinetics Pharmaceuticals Price Target Maintained With a $60.00/Share by HC Wainwright & Co., from 6:57AM ET on Friday Jun 28, 2024 by Dow Jones
6:57AM ET on Friday Jun 28, 2024 by Dow Jones
Jun 18, 2024
Jun 10, 2024
Crinetics Pharmaceuticals Announces June 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), from 6:35PM ET on Monday Jun 10, 2024 by Dow Jones
6:35PM ET on Monday Jun 10, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Crinetics Pharmaceuticals Inc | 3.5B | -11.7x | --- |
Dyne Therapeutics Inc | 3.4B | -8.6x | --- |
Merus NV | 3.6B | -19.6x | --- |
Immunovant Inc | 3.9B | -13.9x | --- |
Vitaspring Biomedical Co. Ltd | 3.1B | 3,311.3x | --- |
Avidity Biosciences Inc | 4.1B | -12.6x | --- |
Company Information
Crinetics Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its Paltusotine, an investigational, oral somatostatin receptor type 2 (SST2) agonist, is in Phase 3 clinical development for acromegaly and Phase 2 clinical development for carcinoid syndrome associated with neuroendocrine tumors. It has demonstrated pharmacologic proof-of-concept in a Phase 1 clinical study for CRN04894, an investigational, oral ACTH antagonist, that is in Phase 2 clinical studies for the treatment of congenital adrenal hyperplasia and Cushing's disease. Its drug candidates are orally delivered, small molecule new chemical entities resulting from in-house drug discovery efforts, including other programs addressing a variety of endocrine conditions such as hyperparathyroidism, polycystic kidney disease, Graves' disease, thyroid eye disease, diabetes and obesity.
Contact Information
- Headquarters
- 10222 Barnes Canyon Rd Bldg 2SAN DIEGO, CA, United States 92121-2711
- Phone
- 858-450-6464
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- Wendell Wierenga
- President, Chief Executive Officer, Co-Founder, Director
- R. Scott Struthers
- Co-Founder, Chief Scientific Officer
- Stephen Betz
- Chief Financial Officer
- Marc Wilson
- Chief Operating Officer
- Jeff Knight
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.5B |
|---|---|
Revenue (TTM) | $2.0M |
Shares Outstanding | 78.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.68 |
EPS | $-3.77 |
Book Value | $7.91 |
P/E Ratio | -11.7x |
Price/Sales (TTM) | 1,751.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -12,571.38% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
